Although the present study is the first to evaluate the serum concentrations of CT-1 in human subjects with NAFLD, the levels of CT-1 had been determined in human subjects with obesity, impaired arterial stiffness, and diabetes. This evidence concerns the gene CTF1 and obesity due to melanocortin 4 receptor deficiency.